Related Experiment Video
Updated: Aug 20, 2025

Mouse Round Spermatid Injection
Published on: January 26, 2024
Effects of inactivated SARS-CoV-2 vaccination on male fertility: A retrospective cohort study
Yehao Dong1, Xiaoyun Li1, Zewu Li1
1Center for Reproductive Medicine, Affiliated Hospital of Jining Medical University, Jining, China.
Abstract:
Numerous studies have revealed severe damage to male fertility from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, raising concerns about the potential adverse impact on reproductive function of the coronavirus disease 2019 (COVID-19) vaccine developed based on the virus. Interestingly, there are several researchers who have studied the impact of the COVID-19 mRNA vaccine since then but have come up with conflicting results. As a near-ideal candidate for mass immunization programs, inactivated SARS-CoV-2 vaccine has been widely used in many countries, particularly in less wealthy nations. However, little is known about its effect on male fertility. Here, we conducted a retrospective cohort study at a single large center for reproductive medicine in China between December 2021 and August 2022. Five hundred and nineteen fertile men with no history of laboratory-confirmed COVID-19 were included and categorized into four groups based on their vaccination status: unvaccinated group (n = 168), one-dose vaccinated group (n = 8), fully vaccinated group (n = 183), and booster group (n = 160). All of them underwent a semen analysis and most had serum sex hormone levels tested. There were no significant differences in all semen parameters and sex hormone levels between the unvaccinated group and either vaccinated group. To account for possible vaccination-to-test interval-specific changes, sub-analyses were performed for two interval groups: ≤90 and >90 days. As expected, most of the semen parameters and sex hormone levels remained unchanged between the control and vaccinated groups. However, participants in vaccinated group (≤90 days) have decreased total sperm motility and increased follicle-stimulating hormone level compared with the ones in unvaccinated group. Moreover, some trends similar to those found during COVID-19 infection and recovery were observed in our study. Fortunately, all values are within the normal range. In addition, vaccinated participants reported few adverse reactions. No special medical intervention was required, and no serious adverse reactions happened. Our study suggests that inactivated SARS-CoV-2 vaccination does not impair male fertility, possibly due to the low frequency of adverse effects. This information reassures young male population who got this vaccine worldwide, and helps guide future vaccination efforts.
Insights
Inactivated SARS-CoV-2 vaccination does not negatively impact male fertility. This study found no significant changes in semen parameters or hormone levels, reassuring men worldwide about vaccine safety for reproductive health.
Area of Science:
- Reproductive Medicine
- Vaccinology
- Andrology
Background:
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is linked to male infertility.
- Concerns exist regarding the impact of coronavirus disease 2019 (COVID-19) vaccines on male reproductive health.
- Limited data exists on the effects of inactivated SARS-CoV-2 vaccines on male fertility.
Purpose of the Study:
- To investigate the effects of inactivated SARS-CoV-2 vaccination on male fertility parameters.
- To assess changes in semen analysis and serum sex hormone levels post-vaccination.
- To provide reassurance regarding the safety of inactivated COVID-19 vaccines for male reproductive function.
Main Methods:
- Retrospective cohort study involving 519 fertile men without a history of COVID-19.
- Participants categorized into unvaccinated, one-dose, fully vaccinated, and booster groups.
- Semen analysis and serum sex hormone levels were evaluated, with sub-analyses based on vaccination-to-test intervals (≤90 and >90 days).
Main Results:
- No significant differences in semen parameters or sex hormone levels were observed between unvaccinated and vaccinated groups overall.
- A subgroup analysis revealed decreased total sperm motility and increased follicle-stimulating hormone levels in the vaccinated group (≤90 days post-vaccination).
- Observed changes were within normal ranges, with minimal and non-serious adverse reactions reported.
Conclusions:
- Inactivated SARS-CoV-2 vaccination does not appear to impair male fertility.
- The low frequency of adverse effects supports the vaccine's safety for male reproductive health.
- Findings reassure the global male population regarding inactivated COVID-19 vaccine use.
Related Concept Videos
Infertility in Males
Infertility in Females
Endometriosis, a condition characterized by abnormal growth of...
Spermatogenesis
Sperm Structure and Semen Composition
Bias in Epidemiological Studies
In Vitro Fertilization
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...

